These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17199853)

  • 1. Estrogens and aspects of prostate disease.
    Prezioso D; Denis LJ; Klocker H; Sciarra A; Reis M; Naber K; Lobel B; Pacik D; Griffiths K
    Int J Urol; 2007 Jan; 14(1):1-16. PubMed ID: 17199853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA; Wang Y; Cunha GR
    Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of estrogens and estrogen receptors in normal prostate growth and disease.
    Prins GS; Korach KS
    Steroids; 2008 Mar; 73(3):233-44. PubMed ID: 18093629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of inflammation and infection in the pathogenesis of prostate carcinoma.
    Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W
    BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgens and the prostate].
    Robel P; Jardin A
    Prog Urol; 1991 Jun; 1(3):476-83. PubMed ID: 1844725
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer and Prostatic Diseases. Editor's comments.
    Freedland SJ
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):295. PubMed ID: 21068743
    [No Abstract]   [Full Text] [Related]  

  • 11. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer prevention.
    Nelson WG
    Curr Opin Urol; 2007 May; 17(3):157-67. PubMed ID: 17414513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of estrogens in normal and abnormal development of the prostate gland.
    Prins GS; Huang L; Birch L; Pu Y
    Ann N Y Acad Sci; 2006 Nov; 1089():1-13. PubMed ID: 17261752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prostate and male hormones after 50 years of age].
    de Lignières B; Martin PM
    Ann Med Interne (Paris); 1988; 139(6):405-9. PubMed ID: 3066250
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and prostate cancer.
    Sugar LM
    Can J Urol; 2006 Feb; 13 Suppl 1():46-7. PubMed ID: 16526982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M; Chorzepa-Nowicka K; Wylot M; Piasecka M; Gaczarzewicz D
    Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of testosterone in the pathogenesis of prostate cancer.
    Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T
    Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.
    Singh PB; Matanhelia SS; Martin FL
    Eur J Cancer; 2008 May; 44(7):928-36. PubMed ID: 18381236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection, inflammation and prostate carcinogenesis.
    Omabe M; Ezeani M
    Infect Genet Evol; 2011 Aug; 11(6):1195-8. PubMed ID: 21397049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.